Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics company, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
The firm had earlier been considering an IPO of Cotiviti, but is now weighing a sale due to a bout of volatility in the stock market, the report said.
Veritas declined to comment on the report.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
An official sales process could start as soon as January, the report added.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Source: Reuters
Can’t stop reading? Read more
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing...
Rightsizing the right way
Rightsizing the right way Rightsizing an organization is never easy. But, it is a normal process...
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion...